Peter is the senior vice president, operations of Global Blood Therapeutics (GBT). Prior to joining GBT, he served as vice president of program leadership at Onyx Pharmaceuticals, Inc., which was acquired by Amgen, Inc. Before that, he was senior director at Onyx, where he led the company’s global, cross-functional product team responsible for the development and commercialization of Kyprolis®. Prior to that, he held a variety of roles of increasing responsibility in Onyx’s commercial organization. Prior to Onyx, Peter was at Chiron Corporation (now Novartis AG) in product marketing.
Peter holds a BA in biology and chemistry from Texas Christian University and an MBA from Washington University.